Related content

Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Zhang Jian   Zhang Weiqing   Huang Shaohong   Li Hui   Li Yun   Chen Huiguo   Wu Weibing   Zhou Wei   Wang Cuiping   Liao Hongying   Gu Lijia  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-11 ,pp. : 849-858

Spandidos Publications

Access to resources Recommend Favorite

Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring

By Gatineau M.  

Targeted Oncology, Vol. 1, Iss. 3, 2006-07 ,pp. : 114-122

Springer Publishing Company

Access to resources Recommend Favorite

Clinical observation of gemcitabine and concomitant three-dimensional conformal radiotherapy in the treatment of locally advanced non-small cell lung cancer

By Cheng Jing  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 311-314

Springer Publishing Company

Access to resources Recommend Favorite

The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer

By Gregorc V.   Darwish S.   Ludovini V.   Pistola L.   De Angelis V.   Mihaylova Z.   Bellezza G.   Sidoni A.   Cavaliere A.   Bucciarelli E.   Massaro G.   Tonato M.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 275-281

Elsevier

Access to resources Recommend Favorite

Clinical observation of Shenmai injection in the treatment for adverse reactions of chemotherapy on advanced non-small cell lung cancer

By Cao Yang  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 81-83

Springer Publishing Company

Access to resources Recommend Favorite